Autoimmune Diseases  >>  Novolin R (recombinant human insulin)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Novolin R (recombinant human insulin) / Novo Nordisk
NCT00567775: Comparison of Human Insulin to Insulin Inhalation Solution in Children With Type 1 Diabetes

Completed
2
27
Europe
human insulin, Actrapid®, Novolin® R, inhaled human insulin
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 1
11/02
11/02
NCT02028078 / 2013-004527-36: Pilot Study Investigating the Feasibility of Determining the Endogenous Glucose Production During a Hypoglycaemia

Completed
2
20
Europe
Insulin human, Actrapid
Medical University of Graz
Type 1 Diabetes Mellitus
03/16
03/16

Download Options